Meduloc provides a platform of solutions for small and long bone fractures using internal fixation.
Meduloc has raised $4.0M in total funding. The most recent round was Series B. The last funding was announced in August 2026.
Meduloc's investors include Andre Ethier, Life Sciences Greenhouse of Pennsylvania, Broad Street Angels, GenHenn Venture, Ben Franklin Technology Partners.
Meduloc is headquartered in Del Mar, United States.
Meduloc provides a platform of solutions for small and long bone fractures using internal fixation.
Meduloc is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Meduloc — Funding & Investors." VCBacked, August 6, 2026, https://www.vcbacked.co/company/meduloc. Accessed September 8, 2026.
VCBacked. (2026). Meduloc — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/meduloc
{{cite web |title=Meduloc — Funding & Investors |url=https://www.vcbacked.co/company/meduloc |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated